BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30558004)

  • 1. The prognostic value of C-reactive protein to albumin ratio in patients with lung cancer.
    Deng TB; Zhang J; Zhou YZ; Li WM
    Medicine (Baltimore); 2018 Dec; 97(50):e13505. PubMed ID: 30558004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role of pre-treatment C-reactive protein/albumin ratio in esophageal cancer: a meta-analysis.
    Liu Z; Shi H; Chen L
    BMC Cancer; 2019 Nov; 19(1):1161. PubMed ID: 31783812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of the modified Glasgow prognostic score in lung cancer: A meta-analysis.
    Jin J; Hu K; Zhou Y; Li W
    PLoS One; 2017; 12(9):e0184412. PubMed ID: 28886134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of pretreatment C-reactive protein/albumin ratio in nasopharyngeal carcinoma: A meta-analysis of published literature.
    Yang X; Liu H; He M; Liu M; Zhou G; Gong P; Ma J; Wang Q; Xiong W; Ren Z; Li X; Zhang X
    Medicine (Baltimore); 2018 Jul; 97(30):e11574. PubMed ID: 30045284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and clinicopathological significance of C-reactive protein/albumin ratio (CAR) in patients with gastric cancer: A meta-analysis.
    Yu J; Liu H; Zeng X; Zhao Y; Jiang D; Lu H; Qian J
    PLoS One; 2021; 16(4):e0250295. PubMed ID: 33901218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of C-reactive protein to albumin ratio in colorectal cancer: A meta analysis.
    Wang F; Li P; Li FS
    Medicine (Baltimore); 2019 Jul; 98(29):e16064. PubMed ID: 31335668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic role of the pretreatment C-reactive protein/albumin ratio in gastric cancer: A systematic review and meta-analysis.
    Yang X; Song X; Zhang L; Wu C
    Medicine (Baltimore); 2020 Mar; 99(10):e19362. PubMed ID: 32150079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of the Glasgow prognostic score in lung cancer: evidence from 10 studies.
    Jin J; Hu K; Zhou Y; Li W
    Int J Biol Markers; 2018 May; 33(2):201-207. PubMed ID: 29076522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of the C-reactive protein to albumin ratio in esophageal cancer: A systematic review and meta-analysis.
    Wang Y; Hu X; Huang Y; Xu WY; Wu YM; Li PF; Che GW
    Kaohsiung J Med Sci; 2020 Jan; 36(1):54-61. PubMed ID: 31512813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of the C-reactive protein to albumin ratio in cancer: An updated meta-analysis.
    Cui X; Jia Z; Chen D; Xu C; Yang P
    Medicine (Baltimore); 2020 Apr; 99(14):e19165. PubMed ID: 32243358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of modified Glasgow prognostic score in patients with esophageal squamous cell cancer: a Meta-analysis.
    Wang Y; Chen L; Wu Y; Li P; Che G
    Nutr Cancer; 2020; 72(7):1146-1154. PubMed ID: 31617767
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic significance of C-reactive protein to albumin ratio in colorectal cancer patients: a meta-analysis.
    Fan Y; Xiang S; Dai Z; Zou C; Wang X; Gao Z
    Int J Colorectal Dis; 2019 Jun; 34(6):1105-1111. PubMed ID: 31016379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein/albumin ratio is a prognostic indicator in Asians with pancreatic cancers: A meta-analysis.
    Fu YJ; Li KZ; Bai JH; Liang ZQ
    Medicine (Baltimore); 2019 Nov; 98(48):e18219. PubMed ID: 31770284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and Clinicopathological Significance of C-Reactive Protein to Albumin Ratio in Patients With Pancreatic Cancer: A Meta-Analysis.
    Xie Q; Wang L; Zheng S
    Dose Response; 2020; 18(2):1559325820931290. PubMed ID: 32647499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of C-reactive protein/albumin ratio in human malignancies: an updated meta-analysis.
    Xu HJ; Ma Y; Deng F; Ju WB; Sun XY; Wang H
    Onco Targets Ther; 2017; 10():3059-3070. PubMed ID: 28790840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of C-reactive protein/albumin ratio on the overall survival of patients with advanced nonsmall cell lung cancers receiving palliative chemotherapy.
    Koh YW; Lee HW
    Medicine (Baltimore); 2017 May; 96(19):e6848. PubMed ID: 28489774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Significance of C-Reactive Protein to Albumin Ratio in Patients with Hepatocellular Carcinoma: A Meta-Analysis.
    Lin N; Li J; Ke Q; Wang L; Cao Y; Liu J
    Dis Markers; 2020; 2020():4867974. PubMed ID: 32963635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment C-Reactive Protein/Albumin Ratio is Associated With Poor Survival in Patients With 2018 FIGO Stage IB-IIA HPV-Positive Cervical Cancer.
    Jiang Y; Gu H; Zheng X; Pan B; Liu P; Zheng M
    Pathol Oncol Res; 2021; 27():1609946. PubMed ID: 34992504
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic value of C-reactive protein to albumin ratio in metastatic colorectal cancer: A systematic review and meta-analysis.
    Pan Y; Lou Y; Wang L
    Medicine (Baltimore); 2021 Nov; 100(46):e27783. PubMed ID: 34797305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of the C-reactive protein to albumin ratio in colorectal cancer: an updated systematic review and meta-analysis.
    Liao CK; Yu YL; Lin YC; Hsu YJ; Chern YJ; Chiang JM; You JF
    World J Surg Oncol; 2021 May; 19(1):139. PubMed ID: 33933070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.